HomeOpen Access NewsDrug Development

Drug Development

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Pfizer vaccine is more than 90% successful in preventing COVID-19

Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.

New research suggests antidepressants could treat childhood cancer

Researchers found that a commonly used antidepressant could treat childhood cancer - successfully stopping growth in lab experiments so far.

EU Pharma Strategy: COVID-19 shows the need for diverse supply chains 

Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.

NHS saves millions on highly effective stroke drugs

Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.

US healthcare: 34% of older people could be prescribed the wrong drugs

A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.

Antimicrobial resistance: The next big pandemic?

Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

New drug offers promising treatment for pancreatic cancer patients

Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.

Finding new antibiotics: The genome way

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.

Cambridge COVID-19 vaccine gets £1.9 million to start trials

The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.

Nightingale hospitals could increase antibiotic resistance

The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.

New cell injection technique could reverse vision loss

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.

Male bias in drug development trials creates overmedication

New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders